Antenatal Betamethasone Does Not Influence Lymphocyte Apoptosis in Preterm Neonates

ABSTRACT

Despite the widespread use of antenatal glucocorticosteroids (GCs), the possibility of adverse effects on the immune response in preterm neonates remains a major concern. GCs stimulate lymphocyte apoptosis, resulting in lymphopenia and functional disorders, which have been associated with sepsis-related death in critically ill neonates. We sought to assess the effect of antenatal betamethasone (BM) on lymphocyte apoptosis in preterm neonates. Fifty preterm neonates exposed to antenatal BM and 50 controls were studied prospectively. Lymphocyte apoptosis was assessed using the annexin-V/propidium iodide (PI) assay, analysis of cell cycle after staining with PI, and intracellular caspase-3 activity. The two groups did not differ significantly as regards absolute lymphocyte counts and the percentage of lymphocytes being annexin-V⁺/PI⁻ (early apoptotic) or lymphocytes in the subG1 peak after staining with PI and those with intracellular caspase-3 activation. The lymphocyte number and apoptosis were not associated with the time elapsed between antenatal BM administration and delivery. A single course of antenatal BM does not influence apoptosis of neonatal lymphocytes. This is of significant importance with respect to the preservation of lymphocyte-associated immune response in preterm neonates.

KEYWORDS

Leukocytes - annexin-V - propidium iodine - caspase-3

REFERENCES

• 1 Roberts D, Dalziel S R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.  Cochrane Database Syst Rev. 2006;  3 CD004454
• 2 Reznikov A, Nosenko N, Tarasenko L, Sinitsyn P, Polyakova L, Mishunina T. Neuroendocrine disorders in adult rats treated prenatally with hydrocortisone acetate.  Exp Toxicol Pathol. 2008;  60 489-497
• 3 Sloboda D M, Moss T J, Li S, Matthews S G, Challis J R, Newnham P. Expression of glucocorticoid receptor, mineralocorticoid receptor, and 11beta-hydroxusteroid dehydrogenase 1 and 2 in the fetal and postnatal ovin hippocampus: ontogeny and effects of prenatal glucocorticoid exposure.  J Endocrinol. 2008;  197 213-220
• 4 Kavelaars A, Cats B, Visser G HA et al.. Ontogeny of the response of human peripheral blood T cells to glucocorticoids.  Brain Behav Immun. 1996;  10 288-297
• 5 Tuckermann J P, Kleiman A, McPherson K G, Reichardt H M. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis.  Crit Rev Clin Lab Sci. 2005;  42 71-104
• 6 Zhang N, Hatrig H, Dzhagalov I, Draper D, He Y W. The role of apoptosis in the development and function of T lymphocytes.  Cell Res. 2005;  15 749-769
• 7 Di Sabatino A, D'Alo S, Millimaggi D et al.. Apoptosis and peripheral blood lymphocyte depletion in coeliac disease.  Immunology. 2001;  103 435-440
• 8 Diaz D, Prieto A, Barcenilla H et al.. Loss of lineage antigens is a common feature of apoptotic lymphocytes.  J Leukoc Biol. 2004;  76 609-615
• 9 Schroeder S, Lindemann C, Decker D et al.. Increased susceptibility to apoptosis in circulating lymphocytes of critically ill patients.  Langenbecks Arch Surg. 2001;  386 42-46
• 10 Hotchkiss R S, Coopersmith C M, Kari I E. Prevention of lymphocyte apoptosis—a potential treatment of sepsis?.  Clin Infect Dis. 2005;  41 S465-S469
• 11 Felmet K A, Mark W H, Clark R SB, Jaffe R, Carcillo J A. Prolonged lymphopenia, lymphoid depletion, and lypoprolactinemia in children with nosocomial sepsis and multiple organ failure.  J Immunol. 2005;  174 3765-3772
• 12 Tian C, Kron G K, Dischert K M, Higginbotham J N, Crowe Jr J E. Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signaling via the IL-4 receptor complex in human neonatal B cell.  Immunology. 2006;  119 54-62
• 13 Marshall-Clarke S, Reen D, Tasker L, Hassan J. Neonatal immunity: how well has it grown up?.  Immunol Today. 2000;  21 35-41
• 14 Bakker J M, Schmidt E D, Kroes H et al.. Effects of neonatal dexamethasone treatment on hypothalamo-pituitary adrenal axis and immune system of the rat.  J Neuroimmunol. 1997;  74 69-76
• 15 Chabra S, Cottrill C, Rayens M K, Cross K, Lipke D, Bruce M. Lymphocyte subsets in cord blood of preterm infants: effect of antenatal steroids.  Biol Neonate. 1998;  74 200-207
• 16 Kavelaars A, van der Pompe G, Bakker J M et al.. Altered immune function in human newborns after prenatal administration of betamethasone: enhanced natural killer cell activity and decreased T cell proliferation in cord blood.  Pediatr Res. 1999;  45 306-312
• 17 Saha N R, Usami T, Suzuki Y. A double staining flow cytometric assay for the detection of steroid induced apoptotic leucocytes in common carp (Cyprinus carpio).  Dev Comp Immunol. 2003;  27 351-363
• 18 Weyts F A, Flik G, Rombout J H, Verbung-van Kemenade B M. Cortisol induces apoptosis in activated B cells, not in other lymphoid cells of the common carp.  Dev Comp Immunol. 1998;  22 551-562
• 19 Walsh C J, Wyffels J T, Bodine A B, Luer C A. Dexamethasone-induced apoptosis in immune cells from peripheral circulation and lymphomyeloid tissues of juvenile clearnose skates, Raja eglanteria.  Dev Comp Immunol. 2002;  26 623-633
• 20 Bianchini R, Nocentini G, Krausz L T et al.. Modulation of pro- and anti- apoptotic molecules in double positive (CD4 + CD8 + ) thymocytes following dexamethasone treatment.  J Pharmacol Exp Ther. 2006;  319 887-897
• 21 Kirsch A H, Mahmood A A, Endres J et al.. Apoptosis of human T-cells: induction by glucocorticoids or surface receptor ligation in vitro and ex vivo.  J Biol Regul Homeost Agents. 1999;  13 80-89
• 22 Lanza L, Scudeletti M, Puppo F et al.. Prednisone increases apoptosis in vitro activated human peripheral blood T lymphocytes.  Clin Exp Immunol. 1996;  103 482-490
• 23 Marchetti M C, Di Marco B, Cifone G, Migliorati G, Riccardi C. Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation.  Blood. 2003;  101 585-593
• 24 Gold R, Buttgereit F, Toyka K V. Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders.  J Neuroimmunol. 2001;  117 1-8
• 25 Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).  Cytometry. 1997;  27 1-20
• 26 Darzynkiewicz Z, Huang X, Okafuji M. Detection of DNA strand breaks by flow and laser scanning cytometry in studies of apoptosis and cell proliferation (DNA replication).  Methods Mol Biol. 2006;  314 81-93
• 27 Schwarze J, Bartmann P. Influence of dexamethasone on lymphocyte proliferation in whole blood cultures of neonates.  Biol Neonate. 1994;  65 295-301
• 28 Kramer B W, Ikegami M, Moss T J, Nitsos I, Newman J P, Jobe A H. Antenatal betamethasone changes cord blood monocyte responses to endotoxin in preterm neonates.  Pediatr Res. 2004;  55 764-768
• 29 Peng C T, Lin H C, Lin Y J, Tsai C H, Yeh T F. Early dexamethasone therapy and blood cell count in preterm infants.  Pediatrics. 1999;  104 476-481
• 30 Fritzsching B, Oberle N, Pauly E et al.. Naïve regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.  Blood. 2006;  108 3371-3378
• 31 El-Ghalbzouri A, Drenou B, Blancheteau V et al.. An in vitro model of allogeneic stimulation of cord blood induction of Fas independent apoptosis.  Hum Immunol. 1999;  60 598-607
• 32 Potestio M, Pawelec G, Di Lorenzo G et al.. Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes.  Exp Gerontol. 1999;  34 659-673
• 33 Belvisi M G, Wicks S L, Battram C H et al.. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.  J Immunol. 2001;  166 1975-1982
• 34 Sternberg E M. Neuroendocrine regulation of autoimmune/inflammatory disease.  J Endocrinol. 2001;  169 429-435
• 35 Webster J I, Tonelli L, Sternberg E M. Neuroendocrine regulation of immunity.  Annu Rev Immunol. 2002;  20 125-163
• 36 De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-B or activator protein-1: molecular mechanisms for gene repression.  Endocr Rev. 2003;  24 488-522
• 37 Ballard P L, Ballard R A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids (review).  Am J Obstet Gynecol. 1995;  173 254-262